Deutsche Bank
ACHV icon

Deutsche Bank’s Achieve Life Sciences ACHV Stock Holding History

Deutsche Bank’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,102
Closed -$45.7K – 3602
2025
Q1 		$45.7K Sell
17,102
-5,363
-24% -$16.7K ﹤0.01% 3390
2024
Q4 		$79.1K Sell
22,465
-400
-2% -$1.81K ﹤0.01% 3351
2024
Q3 		$108K Hold
22,865
– – ﹤0.01% 3193
2024
Q2 		$107K Buy
+22,865
New +$110K ﹤0.01% 3086
2020
Q1 		– Sell
-1,338
Closed -$14K – 4289
2019
Q4 		$14K Buy
+1,338
New +$28.7K ﹤0.01% 4395
2019
Q3 		– Sell
-512
Closed -$19K – 4841
2019
Q2 		$19K Buy
512
+502
+5,020% +$35.5K ﹤0.01% 4820
2019
Q1 		$0 Buy
+10
New +$404 ﹤0.01% 5142
2018
Q4 		– Sell
-10
Closed – – 5132
2018
Q3 		$0 Sell
10
-15
-60% -$949 ﹤0.01% 5331
2018
Q2 		$2K Buy
+25
New +$5.1K ﹤0.01% 5304
2018
Q1 		– Hold
0
– – – 5360
2017
Q4 		– Hold
0
– – – 4973
2017
Q3 		– Sell
-1
Closed -$718 – 4851
2017
Q2 		$0 Hold
1
– – ﹤0.01% 4905
2017
Q1 		$0 Buy
+1
New +$1.21K ﹤0.01% 4873
2016
Q4 		– Hold
0
– – – 4881
2016
Q3 		– Hold
0
– – – 4883
2016
Q2 		– Hold
0
– – – 5151
2016
Q1 		– Hold
0
– – – 5120
2015
Q4 		– Sell
-16
Closed -$67.6K – 5245
2015
Q3 		$78K Sell
16
-36
-69% -$217K ﹤0.01% 4210
2015
Q2 		$266K Buy
52
+51
+5,100% +$253K ﹤0.01% 3744
2015
Q1 		$4K Sell
1
-17
-94% -$83.5K ﹤0.01% 4918
2014
Q4 		$88K Buy
+18
New +$88K ﹤0.01% 4802
2014
Q3 		– Sell
-84
Closed -$583K – 5861
2014
Q2 		$688K Buy
84
+78
+1,300% +$958K ﹤0.01% 3243
2014
Q1 		$147K Buy
6
+5
+500% +$123K ﹤0.01% 4057
2013
Q4 		$23K Sell
1
-10
-91% -$175K ﹤0.01% 4684
2013
Q3 		$220K Buy
11
+5
+83% +$104K ﹤0.01% 4061
2013
Q2 		$133K Buy
+6
New +$134K ﹤0.01% 4059

Other funds holding ACHV

PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank's ACHV Position: Q2 2025 in Review

Deutsche Bank sold out of Achieve Life Sciences (ACHV) in Q2 2025, closing a stake of 17,102 shares — an estimated $45.7K sold.

Deutsche Bank first reported a position in ACHV in Q2 2013 and held it in 20 quarters. The position peaked at $688K in Q2 2014. 65 funds tracked by Wall St. Rank hold ACHV as of Q2 2025.

  • Deutsche Bank reported no remaining Achieve Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 17,102 Achieve Life Sciences shares in Q2 2025, an estimated $45.7K.
  • Deutsche Bank first reported a position in Achieve Life Sciences in Q2 2013 and held it in 20 quarters.
  • Deutsche Bank's Achieve Life Sciences position peaked at $688K in Q2 2014.
  • 65 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.